Jacob Hallen

Jacob Hallen has extensive experience in the pharmaceutical and biotechnology industries, currently serving as an Account Manager for Hematology at BeiGene since November 2022. Previously, Jacob held the position of Senior Cell Therapy Account Specialist at Kite Pharma, promoting CarT therapies for hematologic malignancies. Prior roles include Hematology Consultant at TG Therapeutics, Inc., and Hematology Oncology Consultant at Celgene, where the focus was on supporting the sales of multiple myeloma products. Jacob’s career began at Pharmacia, with additional experience at Novartis in various sales roles across oncology and neuroscience, as well as sales positions at Astellas Pharma. Jacob holds a Bachelor’s degree in Chemistry with a focus on Quantitative Methods and Computer Science from the University of St. Thomas.